Related references
Note: Only part of the references are listed.Glucagon and Glucagon-like Peptide-1 Receptors: Promising Therapeutic Targets for an Effective Management of Diabetes Mellitus
Ghulam Abbas et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
W. Timothy Garvey et al.
DIABETES CARE (2020)
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
Tatsuo Kanda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes
Hao Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
Bhagyalakshmi Nair et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2020)
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Evolution of NAFLD and Its Management
Manpreet S. Mundi et al.
NUTRITION IN CLINICAL PRACTICE (2020)
New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis
Natalia Pydyn et al.
PHARMACOLOGICAL REPORTS (2020)
LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway
Hanbin Chen et al.
STEM CELL RESEARCH & THERAPY (2020)
Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription
Feizhou Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Ke Pei et al.
BIOMED RESEARCH INTERNATIONAL (2020)
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Hideki Fujii et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor
Xiaodong Yan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
Jeffrey Budd et al.
CURRENT DIABETES REPORTS (2020)
Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
Mohammad S. Kuchay et al.
DIABETOLOGIA (2020)
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
Olfa Khalifa et al.
DISEASE MARKERS (2020)
Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
L. Korinkova et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
Hiroaki Yokomori et al.
BMJ OPEN GASTROENTEROLOGY (2020)
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
Siti Aishah Sulaiman et al.
FRONTIERS IN PHYSIOLOGY (2019)
LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease
Jun Liu et al.
BIOSCIENCE REPORTS (2019)
Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
Anna Jeznach-Steinhagen et al.
MEDICINA-LITHUANIA (2019)
Long non-coding RNA H19 promotes the proliferation and invasion of lung cancer cells and regulates the expression of E-cadherin, N-cadherin, and vimentin
Shu Liaol et al.
ONCOTARGETS AND THERAPY (2019)
Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells
Xiaohua Fu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouries et al.
JOURNAL OF HEPATOLOGY (2019)
Role of long non-coding RNA TP73-AS1 in cancer
Caizhi Chen et al.
BIOSCIENCE REPORTS (2019)
Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism
Sophie A. Montandon et al.
SCIENTIFIC REPORTS (2019)
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
Kyle S. McCommis et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Resolving the Paradox of Hepatic Insulin Resistance
Dominic Santoleri et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
Jack Alistair Sargeant et al.
ENDOCRINOLOGY AND METABOLISM (2019)
lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3
Si-Si Jin et al.
EUROPEAN CYTOKINE NETWORK (2019)
Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far
Kankadeb Mishra et al.
NON-CODING RNA (2019)
Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway
Xiang Wang
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial
Christina N. Katsagoni et al.
BRITISH JOURNAL OF NUTRITION (2018)
Functional Classification and Experimental Dissection of Long Noncoding RNAs
Florian Kopp et al.
CELL (2018)
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
Marta Seghieri et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Jordan Rowlands et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Metastasis-Associated Lung Adenocarcinoma Transcript 1 as a Common Molecular Driver in the Pathogenesis of Nonalcoholic Steatohepatitis and Chronic Immune Mediated Liver Damage
Silvia Sookoian et al.
HEPATOLOGY COMMUNICATIONS (2018)
LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method
Junwei Han et al.
SCIENTIFIC REPORTS (2017)
Long noncoding RNAs in cancer: mechanisms of action and technological advancements
Nenad Bartonicek et al.
MOLECULAR CANCER (2016)
Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
Mohammad J. Alkhatatbeh et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
Mi Hae Seo et al.
PLOS ONE (2016)
Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability
Caifeng Yan et al.
SCIENTIFIC REPORTS (2016)
Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
Sokho Kim et al.
SCIENTIFIC REPORTS (2016)
Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
Salma A. Abdelmagid et al.
PLOS ONE (2015)
Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
Paul Richards et al.
DIABETES (2014)
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development
Moritz Eissmann et al.
RNA BIOLOGY (2012)
From the metabolic syndrome to NAFLD or vice versa?
Ester Vanni et al.
DIGESTIVE AND LIVER DISEASE (2010)
Glucagon-Like Peptide-1 Receptor Is Present on Human Hepatocytes and Has a Direct Role in Decreasing Hepatic Steatosis In Vitro by Modulating Elements of the Insulin Signaling Pathway
Nitika Arora Gupta et al.
HEPATOLOGY (2010)
Share Paper
